TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 2.90nMpH: 7.4Assay Description:Compound 2 was examined for its ability to bind human FLAP using a membrane-binding assay. The affinity of Compound 2 for human FLAP was assessed usi...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 3.20nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 4nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 4.20nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 5.90nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 7.10nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 10nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 12nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 13nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 17nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 19nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 20nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 23nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 23nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 29nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 34nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 46nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 51nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 58nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 86nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 110nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 138nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 180nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 220nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 270nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 279nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 300nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 450nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 540nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 542nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 620nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 700nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 870nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Panmira Pharmaceuticals
US Patent
Panmira Pharmaceuticals
US Patent
Affinity DataIC50: 960nMpH: 7.5Assay Description:Compounds are assessed for the ability to bind to FLAP in a binding assay that measures compound-specific displacement of an iodinated (125I) FLAP in...More data for this Ligand-Target Pair